On-Demand Webinar: Cost-Effectiveness Analysis with R? A Discussion
Are you involved in preparing health technology assessment (HTA) submissions and in early health economic modeling as part of drug development decision-making? You won’t want to miss our webinar, “Cost-Effectiveness Analysis with R? A Discussion.” Learn about the pros and cons of R versus Excel in preparing HTA submissions, and the acceptability of R by HTA agencies.
Virtual ISPOR Europe 2021
Attending Virtual ISPOR EU 2021 30 November-3 December? PRECISIONadvisors and PRECISIONheor will be attending with 18 insightful posters, panels, presentations and workshops!
On-Demand Webinar: Oral Oncolytics and Oncology Care Transformation
PRECISIONvalue’s 2021 Care Management Survey found that Oncology was the top condition for which patients were referred for Care Management, and tools, resources and programs for supporting medication adherence were the top type of support that respondents would like to receive from pharmaceutical manufacturers.
LTEN 2021: Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D
Are you attending LTEN 2021, November 8-11? Don’t miss the workshop “Customer-Centric Viewpoints: The Value of Experiential Insights in Market Access L&D” on Wednesday, 11/10 at 3:30pm MST | 5:30pm EDT in the Cottonwood 6 room!
On-Demand Interview: The Science Advisory Board – Precision ADVANCE Aims to Improve Patient Access to Cell and Gene Therapy
Anshul Mangal (President of Project Farma and Precision ADVANCE) and Phil Cyr (SVP, Customer Solutions at Precision Value & Health) sat down with Samantha Black (Editor in Chief at ScienceBoard) to discuss how Precision ADVANCE is driving innovation in the advanced therapy sector by improving patient access through interconnected services across the drug development spectrum.
COVID-19 and Diabetes: Strategies to Catch Up
While new diagnoses of diabetes in adults have slowed in recent years, the pandemic may reverse this trend. Physicians, payers, and pharmaceutical companies all can play a part in mitigating the long-term effects on persons with diabetes. Precision’s Cynthia Miller details how these stakeholders can collaborate to mitigate future damage.
CareTalk Podcast @ HLTH 2021 – Mark Clein Brings Precision to Medicine, But Not Quite at Warp Speed
Co-Founder and CEO of Precision Medicine Group Mark Clein sat down with CareTalk hosts John Driscoll and David E. Williams at HLTH Boston 2021 to discuss the game changing impact of precision medicine on treatments and patient outcomes.
On-Demand Webinar: Closing the Gaps in Diabetes Care: Emerging Tools and Approaches
In 2021, PRECISIONvalue launched a proprietary survey of the care management ecosystem (including payers and health systems) and found diabetes to be one of the top conditions for which individuals are referred for care management.
Upcoming Webinar: The Power of Partnering to Support Healthcare Innovation and Improve Human Health
Join us on October 26th at 12:00pm EDT for a new Precision webinar in partnership with MedStar Health, a nationally-recognized leader in the integration and application of real world data analytics.
HLTH Boston 2021: Driving Diversity in Clinical Trials
Congratulations to Precision’s Mark Clein on moderating a well attended panel at at HLTH Boston 2021. Did you miss “Driving Diversity in Clinical Trials,” where life sciences leaders discussed what they are doing to ensure diversity is deeply ingrained into the planning and execution of all clinical trials, leaving bias in the past?
